Wealth Architects’s GSK GSK Stock Holding History

Wealth Architects’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Sell	3,900 -16	-0.4%	-$846	0.02%	239
2026 Q1	$216K	Buy	+3,916	New	+$212K	0.02%	223
2022 Q3	–	Sell	-3,878	Closed	-$211K	–	181
2022 Q2	$211K	Buy	3,878 +4	+0.1%	+$221	0.04%	167
2022 Q1	$211K	Buy	3,874 +39	+1%	+$2.12K	0.04%	186
2021 Q4	$211K	Buy	+3,835	New	+$199K	0.04%	184
2021 Q3	–	Sell	-4,177	Closed	-$208K	–	190
2021 Q2	$208K	Buy	+4,177	New	+$201K	0.04%	173
2020 Q3	–	Sell	-4,080	Closed	-$208K	–	152
2020 Q2	$208K	Buy	+4,080	New	+$209K	0.06%	126
2020 Q1	–	Sell	-3,741	Closed	-$220K	–	136
2019 Q4	$220K	Buy	+3,741	New	+$208K	0.06%	123
2017 Q3	–	Sell	-3,853	Closed	-$207K	–	128
2017 Q2	$207K	Hold	3,853	–	–	0.08%	111
2017 Q1	$203K	Buy	+3,853	New	+$195K	0.08%	115
2016 Q4	–	Sell	-3,806	Closed	-$205K	–	119
2016 Q3	$205K	Hold	3,806	–	–	0.09%	106
2016 Q2	$206K	Buy	+3,806	New	+$201K	0.1%	104
2016 Q1	–	Sell	-4,222	Closed	-$213K	–	117
2015 Q4	$213K	Sell	4,222 -596	-12%	-$30.4K	0.11%	108
2015 Q3	$232K	Buy	4,818 +830	+21%	+$43.2K	0.12%	98
2015 Q2	$208K	Hold	3,988	–	–	0.11%	113
2015 Q1	$230K	Sell	3,988 -194	-5%	-$11.1K	0.13%	89
2014 Q4	$223K	Buy	+4,182	New	+$234K	0.13%	90

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wealth Architects's GSK Position: Q2 2026 in Review

Wealth Architects reduced its GSK (GSK) stake by 0.41% in Q2 2026, selling an estimated $846 and leaving 3,900 shares worth $204K. The position accounts for 0.02% of the portfolio, ranked #239.

Wealth Architects first reported a position in GSK in Q4 2014 and has held it in 17 quarters since. The position peaked at $232K in Q3 2015. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Wealth Architects held 3,900 shares of GSK worth $204K as of Q2 2026.
Wealth Architects sold 16 GSK shares in Q2 2026, an estimated $846.
GSK made up 0.02% of Wealth Architects's portfolio in Q2 2026, its #239 holding.
Wealth Architects first reported a position in GSK in Q4 2014 and has held it in 17 quarters since.
Wealth Architects's GSK position peaked at $232K in Q3 2015.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Wealth Architects's 13F filing for Q2 2026, filed 23 Jul 2026.